BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19596937)

  • 1. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients.
    Sakakura C; Hamada T; Miyagawa K; Nishio M; Miyashita A; Nagata H; Ida H; Yazumi S; Otsuji E; Chiba T; Ito K; Ito Y
    Anticancer Res; 2009 Jul; 29(7):2619-25. PubMed ID: 19596937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
    Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
    Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
    Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
    Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction.
    Lo YM; Wong IH; Zhang J; Tein MS; Ng MH; Hjelm NM
    Cancer Res; 1999 Aug; 59(16):3899-903. PubMed ID: 10463578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients.
    Koike H; Ichikawa D; Ikoma H; Otsuji E; Kitamura K; Yamagishi H
    J Surg Oncol; 2004 Sep; 87(4):182-6. PubMed ID: 15334633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
    Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
    J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY; Li JK; Shen Y; Yu L; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy].
    Tani N; Ichikawa D; Ikoma D; Ikoma H; Sai S; Tomita H; Okamoto K; Kikuchi S; Fujiwara H; Ochiai T; Ueda Y; Otsuji E; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1720-2. PubMed ID: 17212086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spreading of methylation within RUNX3 CpG island in gastric cancer.
    Homma N; Tamura G; Honda T; Matsumoto Y; Nishizuka S; Kawata S; Motoyama T
    Cancer Sci; 2006 Jan; 97(1):51-6. PubMed ID: 16367921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
    Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
    Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
    Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
    Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
    Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.